Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Accenture
Teva
Covington
Farmers Insurance
AstraZeneca
Moodys
Harvard Business School
Queensland Health
Novartis

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,861,386

« Back to Dashboard

Summary for Patent: 5,861,386
Title: Method for treating and preventing secondary hyperparathyroidism
Abstract:A method for preventing loss of bone mass or bone mineral content in a human being suffering from secondary hyperparathyroidism by administering a sufficient amount of 1.alpha.--OH vitamin D.sub.2, 1.alpha.,24(S)--(OH).sub.2 vitamin D.sub.2, 1.alpha.--OH vitamin D.sub.4 or l.alpha.,24(R)--(OH).sub.2 vitamin D.sub.4.
Inventor(s): Knutson; Joyce C. (Madison, WI), Bishop; Charles W. (Verona, WI), Mazess; Richard B. (Madison, WI)
Assignee: Bone Care International, Inc. (Madison, WI)
Application Number:08/907,658
Patent Claim Types:
see list of patent claims
Use; Formulation; Delivery; Composition;

Drugs Protected by US Patent 5,861,386

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,861,386

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 247817 ➤ Sign Up
Austria 114471 ➤ Sign Up
Austria 250566 ➤ Sign Up
Austria 258796 ➤ Sign Up
Austria 347366 ➤ Sign Up
Australia 2002322346 ➤ Sign Up
Australia 2002346596 ➤ Sign Up
Australia 2003225053 ➤ Sign Up
Australia 2004220622 ➤ Sign Up
Australia 3656193 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Medtronic
UBS
Citi
Fish and Richardson
Accenture
Moodys
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot